Art

J-GLOBAL ID：201002209502881484   Reference number：10A0087591

Anti-HBs-Positive Liver Failure Due to Hepatitis B Virus Reactivation Induced by Rituximab

症例報告 リツキシマブ誘発B型肝炎ウイルス再活性化による抗HBs陽性肝不全

Author (11)： SERA Toshiki (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine) ,  HIASA Yoichi (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine) ,  MICHITAKA Kojiro (Dep. of Endoscopic Medicine, Ehime Univ. Graduate School of Medicine) ,  KONISHI Ichiro (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine) ,  MATSUURA Kana (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine) ,  TOKUMOTO Yoshio (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine) ,  MATSUURA Bunzo (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine) ,  KAJIWARA Takeshi ,  MASUMOTO Toshikazu ,  HORIIKE Norio (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine) ,  ONJI Morikazu (Dep. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 45  Issue： 11  Page： 721-724 (J-STAGE)  Publication year： 2006 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *monoclonal antibody ,...
Semi thesaurus term： virus marker ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0087591&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (1)： Immunotherapy for tumors  (GE03035B)

Reference (19)：

• 1. World Health Organization: Hepatitis B. World Health Organization Fact Sheet 204 (Revised October 2000). WHO Web site. 2000. http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
• 2. Lok AS, Liang RH, Chiu EK et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study. Gastroenterology 100: 182-188, 1991.
• 3. Dervite I, Hober D, Morel P. Acute hepatitis b in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 344: 68-69, 2001.
• 4. Westhoff TH, Jochimsen F, Schmittel A et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102: 1930, 2003.
• 5. Tsutsumi Y, Kawamura T, Saitoh S et al. Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leuk Lymphoma 45: 627-629, 2004.

Terms in the title (6)： 症例報告 ,  リツキシマブ ,  誘発 ,  B型肝炎ウイルス ,  再活性化 ,  肝不全